Nuwellis, Inc. (NUWE)

Revance Therapeutics Revenue

Nuwellis had revenue of $1.90M in the quarter ending March 31, 2025, with 2.53% growth. This brings the company's revenue in the last twelve months to $8.79M, down -1.21% year-over-year. In the year 2024, Nuwellis had annual revenue of $8.74M, down -1.40%.

• Revenue (ttm): $8.79M
• Revenue Growth: -1.21%
• P/S Ratio: 0.06
• Revenue / Employee: $231,237
• Employees: 38
• Market Cap: 1.04M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	8.74M	-124.00K	-1.40%
Dec 31, 2023	8.86M	321.00K	3.76%
Dec 31, 2022	8.54M	622.00K	7.85%
Dec 31, 2021	7.92M	480.00K	6.45%
Dec 31, 2020	7.44M	1.93M	35.02%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.